Teladoc Health (TDOC) Cash from Investing Activities (2014 - 2026)

Teladoc Health has reported Cash from Investing Activities for 13 years, with the latest figure at -$41.6 million in Q2 2026.

• Quarterly Cash from Investing Activities rose 30.33% year-over-year to -$41.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$161.2 million (up 33.89% YoY) and the FY2025 annual result came in at -$266.0 million, down 114.43% from the prior year.
• Cash from Investing Activities slipped to -$41.6 million in Q2 2026 per TDOC's latest filing, from -$36.5 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$27.6 million in Q1 2022 and troughed at -$123.3 million in Q1 2025.
• A 5-year average of -$44.0 million and a median of -$37.1 million in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities tumbled 1968.13% in 2022, then jumped 70.37% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$53.9 million in 2022, then jumped by 32.26% to -$36.5 million in 2023, then climbed by 18.8% to -$29.6 million in 2024, then slipped by 15.77% to -$34.3 million in 2025, then decreased by 21.19% to -$41.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$41.6 million, -$36.5 million, and -$34.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.